Canada· CA-DIN-02518376
LEQVIO
A inclisiran product containing inclisiran (inclisiran sodium), registered in Canada by NOVARTIS PHARMACEUTICALS CANADA INC. The same ATC class is registered in 14 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Inclisiran is registered in 14 of 19 countries.
Countries holding a registration under ATC C10AX16 (inclisiran), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 9 of them publish a price we can compare per daily dose
Inclisiran · ATC C10AX16
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- INCLISIRAN (INCLISIRAN SODIUM)
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Country
- Canada (CA)
- ATC code
- C10AX16
- ATC class
- Inclisiran
- Defined daily dose
- 1.6 mg, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Inclisiran in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayLeqvioOrifarm AS
- SpainLEQVIO 284 mg SOLUCION INYECTABLE EN JERINGA PRECARGADANovartis Europharm Limited
- IrelandLeqvio 284 mg solution for injection in pre-filled syringeNovartis Europharm Limited
- IcelandLeqvioNovartis Europharm Limited*
- ItalyLEQVIO*1 siringa preriempita SC 1,5 ml 284 mg 189 mg/ml con dispositivo di protezione dell'agoNOVARTIS EUROPHARM LTD
- NetherlandsLeqvio 284 mg oplossing voor injectie in een voorgevulde spuitNovartis Europharm Limited
- PolandLeqvioNovartis Europharm Limited
- SwedenLeqvio 284 mg Injektionsvätska, lösning i förfylld sprutaNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Leqvio
- Liechtenstein · Leqvio
- Norway · Leqvio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/89e50e40-13ef-4742-94dd-a9b48ce99d55 GET /v1/drugs/89e50e40-13ef-4742-94dd-a9b48ce99d55?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02518376",
"form": "SOLUTION",
"class": "Human",
"routes": [
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "C10AX16",
"schedule": [
"Prescription"
],
"drug_code": "100766",
"strengths": [
"284 MG"
],
"ahfs_class": null,
"substances": [
"INCLISIRAN (INCLISIRAN SODIUM)"
],
"product_categorization": null
}See everything about inclisiran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.